Genetic test for predicting the risk of male or female hair loss

The HairDX Genetic test for predicting the risk of male or female hair loss became available in Hong Kong and Singapore today with the announcement of a distribution agreement between Global Beauty International (HK) Limited (GBIL) and HairDX, LLC. Global Beauty International will introduce the genetic test to all Svenson Hair Centres in Hong Kong and Singapore. HairDX’s easy to use genetic test provides an understandable genetic analysis of a man’s or woman’s likelihood of developing Androgenetic Alopecia, the most common type of hair loss.

Headquartered in Irvine, CA, DermaGenoma, Inc. is a molecular dermatology company founded by leading researchers and specialists in genetics and dermatology. The company is dedicated to the research and development of new diagnostics and prescription based therapies for skin conditions tailored to an individual’s genetic makeup.

The company introduced HairDX, a genetic screening test for Female and Male Pattern Baldness (Androgenetic Alopecia). The HairDX test collection kit is listed with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and the United States Food and Drug Administration (FDA) as a Class I medical device. It is also available as a CE Marked product under the European In-Vitro Diagnostic Directive.

Source: Medical News Today